Best Insurance for Wegovy in 2026What Actually Covers It (and What Doesn't)

Why “Best Insurance for Wegovy” Doesn't Have One Answer

No insurance company covers Wegovy for everyone. Two people with the same insurer can get completely different answers because their employers picked different benefit packages. The brand on the card matters less than three things:

1. 1. Did your employer opt in?

   If you have a self-funded employer plan, the employer decides whether weight-loss medications are covered at all. The KFF 2025 Employer Health Benefits Survey found 43% of employers with 5,000+ workers cover GLP-1s for weight loss, dropping to 30% at 1,000\u20134,999 workers, and just 16% at 200\u2013999 workers.

2. 2. Which PBM runs your formulary?

   A PBM (Pharmacy Benefit Manager) is the middleman between your insurance and the pharmacy \u2014 they decide which drugs are “preferred.” Aetna runs on CVS Caremark. UnitedHealthcare runs on OptumRx. Cigna runs on Express Scripts. In July 2025, CVS Caremark made Wegovy injection 2.4 mg the preferred GLP-1 on its commercial template formularies \u2014 the strongest single signal in the industry right now.

3. 3. Can you meet the PA criteria?

   Most plans require BMI \u226530, or BMI \u226527 with a related health condition like type 2 diabetes, high blood pressure, sleep apnea, or high cholesterol.

Which Insurance Plans Are Most Likely to Cover Wegovy in 2026?

We rated 12 insurer/plan archetypes on five factors: coverage access likelihood, prior authorization strictness, typical out-of-pocket, plan-to-plan variability, and 2026 direction. Plan variability is high \u2014 two readers with the same insurer can have completely different coverage. The scorecard is your starting point; your specific plan's formulary is the final word.

How Do I Check if My Plan Actually Covers Wegovy?

Look up Wegovy on your plan's formulary, confirm which indication is covered, read the PA criteria, estimate your out-of-pocket using your deductible status, then run a test claim at the pharmacy. Do this before paying for any membership or telehealth visit, because a prescription doesn't guarantee insurance pays.

What Does Prior Authorization for Wegovy Require?

Prior authorization is your insurer asking your doctor to prove you meet specific medical criteria before they'll pay for Wegovy. Most commercial plans require it. Per GoodRx Research (January 2026), more than 88% of commercially insured people with weight-loss GLP-1 coverage face additional restrictions \u2014 prior authorization, step therapy, or quantity limits. Even when you're “covered,” the system makes you work for it.

What insurers typically require in an initial PA submission:

• \u2713BMI within the last 30 days \u2014 Most plans require ≥30, or ≥27 with a weight-related condition
• \u2713Comorbidity documentation \u2014 High blood pressure, type 2 diabetes, sleep apnea, high cholesterol, established cardiovascular disease
• \u27136+ months of diet and exercise effort \u2014 Visit notes, dietitian referrals, a documented weight-loss program
• \u2713Past weight-loss medications \u2014 What you’ve tried (Phentermine, Contrave, Qsymia, Saxenda) and why it didn’t work
• \u2713Recent labs \u2014 A1C (a 3-month average blood sugar), lipid panel

The 4 Most Common Denial Reasons \u2014 and What to Do

How Much Does Wegovy Cost With Insurance or Without in 2026?

With commercial insurance that covers Wegovy plus the Wegovy Savings Offer, eligible patients may pay as little as $25 per month. Novo Nordisk has stated 90% of Wegovy patients with commercial insurance have a $0\u2013$25 monthly copay. Without coverage, the cheapest verified FDA-approved path is $149/month for the Wegovy pill (1.5 mg or 4 mg) through NovoCare Pharmacy.

The “$25 isn't really $25” caveat: if you have a high-deductible plan, you may pay full price until you meet your deductible, then drop to $25. Some employer plans use copay accumulators where manufacturer copay payments don't count toward your deductible \u2014 verify with HR.

What Should I Do if My Plan Excludes Wegovy?

If your insurance doesn't cover Wegovy and won't budge, you have three FDA-approved cash-pay paths: the Wegovy pill at $149/month through NovoCare Pharmacy, the multi-month subscription at $249/month for the injection with a 12-month commitment, or the cardiovascular or MASH indication pathway if your medical history qualifies.

Does Medicare Cover Wegovy?

Standard Medicare Part D excludes Wegovy when prescribed for weight loss alone. Medicare can cover Wegovy for cardiovascular risk reduction in adults with established heart disease plus overweight or obesity, or for noncirrhotic MASH where the plan covers that indication. The new Medicare GLP-1 Bridge program launches July 1, 2026 and runs through December 31, 2027, offering Wegovy at $50 per monthly supply for eligible Medicare beneficiaries. This is the biggest Medicare coverage shift in over 20 years.

The Baseline Medicare Rule (Until July 2026)

A federal statute from 2003 has historically excluded weight-loss drugs from Medicare Part D. Workarounds exist: in March 2024, Wegovy was approved to reduce cardiovascular risk in adults with established heart disease and overweight or obesity. In August 2025, Wegovy was approved for noncirrhotic MASH. Medicare Part D plans can cover Wegovy under either indication when the plan covers it on its formulary.

What Medicare Beneficiaries Should Do Right Now

1. 1.Check whether you qualify under the cardiovascular or MASH indication — these work today, before the Bridge launches
2. 2.Confirm your Part D status — the Bridge is available nationwide for eligible beneficiaries enrolled in a PDP or MA-PD plan
3. 3.Don’t expect manufacturer coupons or savings cards to work — they can’t be combined with Medicare Part D under federal law
4. 4.If you’re below 65 and approaching Medicare, the Bridge program may be worth waiting for if cost is the blocker

For the deep-dive on the Bridge program, including exact eligibility and the application timeline, see our CMS BALANCE Model GLP-1 Explained (2026\u20132027).

Does Medicaid Cover Wegovy?

Medicaid coverage of Wegovy depends entirely on your state. As of January 2026, 13 state Medicaid programs cover one or more GLP-1s for obesity treatment under fee-for-service, per KFF. That doesn't guarantee Wegovy specifically \u2014 verify Wegovy by name on your state's preferred drug list or managed-care formulary.

What Medicaid Beneficiaries Should Do

1. 1.Search your state Medicaid formulary directly — search “Wegovy” on your state’s Medicaid drug list
2. 2.If your state ended coverage in 2026, your realistic options are (a) the cardiovascular or MASH indication if you qualify, (b) the Medicare Bridge if you’re 65+, or (c) NovoCare cash-pay at $149/month for the pill
3. 3.Medicaid beneficiaries cannot use the Wegovy Savings Offer — federal program restrictions
4. 4.Watch for BALANCE expansion starting May 2026 — CMS is negotiating directly with manufacturers for lower Medicaid GLP-1 prices

What Should I Do if Wegovy Is Denied?

A Wegovy denial is worth appealing when the plan can cover Wegovy and the denial reason is fixable. If the denial is a benefit exclusion, the stronger move is usually cash-pay, a different indication route, or a plan-change strategy at your next open enrollment.

How Do I Pick a Health Plan That Covers Wegovy During Open Enrollment?

If you're choosing health insurance during open enrollment and Wegovy access matters to you, ignore the insurance brand. Ask three questions: (1) Does this plan cover anti-obesity medications? (2) Which PBM administers the formulary? (3) What are the prior authorization rules?

The Three Open-Enrollment Questions to Ask HR

1. 1. Does this plan cover anti-obesity medications as a benefit category?

   This catches the fundamental question: did your employer opt in?

2. 2. Which Pharmacy Benefit Manager administers the prescription benefit?

   CVS Caremark has Wegovy as preferred on its commercial template formularies. OptumRx and Express Scripts are stable but plan-specific.

3. 3. What are the prior authorization criteria for GLP-1 weight-loss medications?

   Get the criteria in writing. If it lists BMI ≥40 or “must have failed three other medications,” that’s a much higher hurdle than ≥30 with a comorbidity.

The HR Script You Can Copy and Paste

“I'm comparing benefit options and need to verify GLP-1 medication coverage. Specifically: Is Wegovy on the formulary? Does the plan cover anti-obesity medications, or is that an excluded benefit category? Which PBM manages the prescription benefit? What are the prior authorization criteria \u2014 including BMI threshold, comorbidity requirements, and step therapy? Can you send me the written formulary and PA criteria PDF? Are there any planned formulary changes for 2026 or 2027 I should know about?”

Watch for 2026 Dropouts

Marketplace Plans

Most ACA Marketplace plans rarely cover Wegovy for weight loss. KFF's 2024 federal Marketplace analysis found just 1% of Marketplace prescription drug plans covered Wegovy for obesity. Verify the specific 2026 plan formulary on the carrier's website before enrolling.

Does Insurance Cover the Wegovy Pill Differently From the Pen?

Coverage rules can differ. Wegovy injection 2.4 mg has been on the market longer and is the form CVS Caremark named as the preferred GLP-1 on its commercial template formularies effective July 1, 2025. The Wegovy pill (oral semaglutide tablets) launched in January 2026 after FDA approval in late 2025, and some insurers may not yet have the pill on formulary or may apply different prior authorization criteria. Wegovy HD 7.2 mg (FDA-approved March 2026) is still being added to many formularies.

The cash-pay prices differ too: NovoCare lists $149/month for the pill at 1.5 mg and 4 mg versus $349/month for the injection at most doses. The pill is currently the cheapest verified FDA-approved monthly Wegovy path.

Can Wegovy Be Covered for MASH if My Plan Excludes Weight Loss Coverage?

Yes, sometimes. Wegovy is FDA-approved for noncirrhotic MASH with moderate-to-advanced liver fibrosis (FDA accelerated approval, August 15, 2025). UnitedHealthcare's 2026 commercial non-formulary Wegovy policy allows Wegovy injection for MASH even when weight-loss coverage is excluded. Coverage typically requires:

• \u2013A documented MASH diagnosis with stage F2 to F3 liver fibrosis
• \u2013Liver biopsy or non-invasive testing supporting the diagnosis
• \u2013Standard-of-care lifestyle interventions (reduced-calorie diet, increased physical activity)
• \u2013Prior authorization with the indication clearly documented

Can Wegovy Coverage Change After It's Approved?

Yes. Your Wegovy approval can be modified or revoked at renewal. Three specific things to watch for:

What Should I Verify Before Paying Cash for Wegovy?

Before you pay cash, sign up for any membership, or assume your insurance won't cover Wegovy, verify these 10 things:

• 1Wegovy is on my plan’s formulary (search “Wegovy” in the member portal)
• 2My plan covers it for my indication (weight management, cardiovascular risk reduction, or MASH)
• 3Prior authorization criteria are visible (BMI, comorbidities, lifestyle documentation)
• 4My doctor can document the required indication
• 5I know my deductible status (have I hit it this year?)
• 6I’m eligible for the Wegovy Savings Offer (commercial insurance only, not Medicare/Medicaid/TRICARE)
• 7I know my preferred pharmacy channel (retail, mail-order, specialty)
• 8I know the renewal criteria (typically ≥5% weight loss documented)
• 9My plan does not exclude weight-loss medications as a benefit category
• 10If denied, I have a clear next step (appeal vs. cash-pay)

How We Ranked Wegovy Insurance Paths

Refresh Cadence

What We Verified Directly

• \u2713NovoCare cash-pay pricing at NovoCare.com (May 8, 2026)
• \u2713Wegovy Savings Offer terms at Wegovy.com (May 8, 2026)
• \u2713Ro Body pricing and Wegovy Insurance Coverage Checker at Ro.co (May 8, 2026)
• \u2713Multi-month subscription pricing and partner list in Novo Nordisk’s March 31, 2026 announcement
• \u2713CVS Caremark Wegovy preferred-GLP-1 status on commercial template formularies (effective July 1, 2025)
• \u2713UnitedHealthcare PA Notification Program 2026 P 1114-20 (P&T approval February 2026)
• \u2713FDA prescribing information for Wegovy (semaglutide injection and tablets)

Frequently Asked Questions About the Best Insurance for Wegovy

What is the best insurance for Wegovy in 2026?

The best insurance for Wegovy in 2026 is the specific plan that lists Wegovy as covered for your indication, has prior authorization criteria you can satisfy, and lets you use the manufacturer savings offer if you have commercial insurance. In our 2026 scorecard, Aetna plans administered by CVS Caremark rank highest because Wegovy injection 2.4 mg is preferred on CVS Caremark's commercial template formularies effective July 1, 2025. Employer opt-in still decides whether the benefit applies to your specific plan.

Does Blue Cross Blue Shield cover Wegovy?

Some BCBS plans cover Wegovy with prior authorization; others exclude it. BCBS Massachusetts is ending GLP-1 coverage except for type 2 diabetes upon plan renewal starting January 1, 2026, and Health New England says GLP-1 medications will no longer be covered for weight loss for commercial members as of January 1, 2026 unless the employer chooses to continue coverage. Coverage varies by which BCBS company, plan type (employer / FEP / Medicaid / Marketplace), and your specific plan's formulary.

Does Aetna cover Wegovy?

Aetna-administered commercial plans can cover Wegovy with prior authorization when the plan includes weight-loss medication coverage. CVS Caremark — Aetna's pharmacy benefit manager — made Wegovy injection 2.4 mg the preferred GLP-1 on its commercial template formularies effective July 1, 2025, which is why Aetna/CVS ranks high in our scorecard. Your specific plan formulary and employer benefit design still decide the real answer.

Does UnitedHealthcare cover Wegovy?

Many UnitedHealthcare commercial plans can cover Wegovy with prior authorization when the employer or plan client opts into the weight-loss medication program. UHC's 2026 commercial weight-loss medication coverage policy (Program 2026 P 1114-20) describes the weight-loss drug program as optional for clients or businesses that elected to cover these products. UHC requires BMI ≥30, or ≥27 with a comorbidity such as diabetes, hypertension, sleep apnea, or dyslipidemia.

Does Cigna cover Wegovy?

Cigna-administered plans can cover Wegovy with prior authorization when the plan includes the weight-loss GLP-1 benefit. Cigna has a national class-wide GLP-1 PA policy with BMI and age thresholds plus quantity limits, but employer or plan client design controls whether the benefit exists.

Does Kaiser cover Wegovy?

Kaiser Permanente coverage is region- and plan-specific. Third-party reporting suggests stricter Kaiser GLP-1 weight-management criteria than some commercial insurers. Verify with your specific Kaiser regional plan before assuming coverage.

Does Medicare cover Wegovy?

Standard Medicare Part D excludes Wegovy when prescribed for weight loss alone. Medicare can cover Wegovy when prescribed to reduce cardiovascular event risk in adults with established cardiovascular disease and overweight or obesity, or for noncirrhotic MASH where the plan covers that indication. The CMS Medicare GLP-1 Bridge launches July 1, 2026 and offers Wegovy at $50 per monthly supply for eligible Medicare Part D beneficiaries (PDP or MA-PD), through December 31, 2027.

Does Medicaid cover Wegovy?

Medicaid coverage depends entirely on your state. As of January 2026, 13 state Medicaid programs cover one or more GLP-1s for obesity treatment under fee-for-service, per KFF. The 13 states are Delaware, Kansas, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, North Carolina, Rhode Island, Tennessee, Utah, Virginia, and Wisconsin. Four states ended coverage in late 2025 / early 2026 (California, New Hampshire, Pennsylvania, South Carolina). Verify Wegovy specifically on your state's preferred drug list.

How much is Wegovy with insurance?

With commercial insurance that covers Wegovy plus the Wegovy Savings Offer, eligible patients may pay as little as $25 per month (Novo Nordisk has stated 90% of Wegovy patients with commercial insurance have a $0–$25 monthly copay; max savings $100/month, government beneficiaries excluded). Without coverage, the cheapest verified FDA-approved path is $149/month for the Wegovy pill through NovoCare Pharmacy, or $349/month for the injection.

Why won't my insurance cover Wegovy?

The most common reasons: (1) your employer didn't opt into weight-loss medication coverage, (2) your plan requires step therapy with cheaper alternatives first, (3) your BMI doesn't meet the plan's threshold (typically ≥30, or ≥27 with comorbidity), or (4) the prior authorization documentation was incomplete. Most ACA Marketplace plans, standard Medicare Part D for weight loss, and most state Medicaid programs exclude Wegovy.

What if my employer plan excludes Wegovy?

You have three realistic paths: (1) NovoCare cash-pay at $149/month for the pill or $349/month for the injection, (2) the multi-month subscription program at $249/month with a 12-month commitment through Ro, WeightWatchers, or LifeMD (with Hims & Hers, Sesame, and others coming online soon), or (3) the cardiovascular risk reduction or MASH indication if your medical history qualifies you for one of Wegovy's other approved uses.

How do I get my insurance to pay for Wegovy?

Document your BMI within the past 30 days, your weight-related comorbidities, your prior weight-loss attempts, and recent labs. Have your doctor submit the prior authorization with everything in the initial submission — incomplete PAs are the #1 reason for denials. If denied, file a formal appeal within 180 days; ask whether a peer-to-peer review is available, and use the cardiovascular or MASH indication if you qualify.

How long does Wegovy prior authorization take?

PA response times vary by plan. Many insurers respond within 5–14 business days; some plans use automated PA systems that respond faster. Once approved, your PA is typically valid for 30 days to over 1 year, depending on your plan.

Can I use the Wegovy savings card with Medicare or Medicaid?

No. The Wegovy Savings Offer is restricted to commercial (non-government) insurance. Medicare, Medicaid, and TRICARE beneficiaries are not eligible.

Is the $25/month Wegovy real?

Yes, for eligible commercially insured patients whose plans cover Wegovy. The savings card caps savings at $100/month off the list price, so if your insurance pays most of the cost, your copay can drop to as little as $25. Novo Nordisk has stated 90% of Wegovy patients with commercial insurance have a $0–$25 monthly copay.

What if my plan covers Ozempic but not Wegovy?

Don't assume the drugs are interchangeable for insurance purposes. Ozempic is FDA-approved for type 2 diabetes; Wegovy is approved for chronic weight management, cardiovascular risk reduction, and MASH. Your plan's coverage depends on the FDA-approved indication, not the active ingredient. Ask your doctor and insurer which medication is covered for your documented diagnosis.

Does insurance cover the Wegovy pill the same as the pen?

Coverage rules can differ. The Wegovy injection has been on the market longer, and CVS Caremark named the 2.4 mg injection as the preferred GLP-1 on its commercial template formularies effective July 1, 2025. The Wegovy pill is newer (FDA-approved late 2025) and may not yet be on every formulary or may have different prior authorization rules. Wegovy HD 7.2 mg, approved in March 2026, may also be added to formularies on a different timeline.

Can Wegovy be covered for MASH if weight loss isn't covered?

Sometimes. UnitedHealthcare's 2026 commercial non-formulary Wegovy policy allows Wegovy injection for MASH even when weight-loss coverage is excluded. Ask your doctor whether you meet the FDA-approved criteria for noncirrhotic MASH with moderate-to-advanced fibrosis, and whether the prior authorization should be submitted under the MASH indication if it applies.

The Bottom Line: Where to Start by Situation

Sources Verified for This Guide

• \u2013Novo Nordisk NovoCare pricing and savings program documentation (verified May 8, 2026)
• \u2013Wegovy.com cost and coverage page (verified May 8, 2026)
• \u2013Wegovy FDA prescribing information (current label)
• \u2013FDA approval announcements: Wegovy weight management (2021), cardiovascular risk reduction (March 2024), MASH (August 15, 2025), Wegovy HD 7.2 mg (March 2026)
• \u2013CVS Caremark commercial template formulary — Wegovy injection 2.4 mg preferred GLP-1, effective July 1, 2025
• \u2013UnitedHealthcare PA Notification: Plans with Weight Loss/Appetite Suppression Medication Coverage, Program 2026 P 1114-20 (P&T approval February 2026)
• \u2013Cigna Glucagon-Like Peptide-1 Agonists Prior Authorization Policy
• \u2013KFF Medicaid Coverage of and Spending on GLP-1s, January 16, 2026
• \u2013KFF 2025 Employer Health Benefits Survey
• \u2013KFF, “Costly GLP-1 Drugs are Rarely Covered for Weight Loss by Marketplace Plans”
• \u2013GoodRx Research, “Insurance Coverage for GIP and GLP-1 Agonists Like Wegovy and Ozempic,” January 2026
• \u2013CMS Medicare GLP-1 Bridge program (cms.gov/medicare/coverage/prescription-drug-coverage/medicare-glp-1-bridge)
• \u2013CMS press release, “Coming Soon: CMS to Provide $50 Monthly Access to GLP-1 Medications for Medicare Beneficiaries”
• \u2013CMS BALANCE Model documentation
• \u2013Novo Nordisk announcement, “Multi-month subscription program for FDA-approved Wegovy,” March 31, 2026
• \u2013Blue Cross Blue Shield of Massachusetts GLP-1 coverage update
• \u2013Health New England GLP-1 Coverage Update
• \u2013TRICARE Pharmacy Program Wegovy coverage page
• \u2013Ro current pricing and Wegovy availability (ro.co)
• \u2013The SELECT trial (Wegovy cardiovascular outcomes)
• \u2013The ESSENCE trial (Wegovy MASH outcomes)